Bristol Will Buy Diabetes Drug Maker

Bristol-Myers Squibb said it will buy diabetes drug maker Amylin in a $7 billion deal that will intensify the competition to treat the growing number of people afflicted with the disease.

  • Pfizer and Merck are Big Pharma's crown jewels - Khaleej Times
    ... exchange, I prefer to buy fear and ... rock bottom, the branded drug market ... to Novartis and Bristol Myers ... hepatitis C, ...
    07/5/2015 - 1:36 pm | View Link
  • Hidden in Plain Sight: 5 Best Stocks in Pharmaceuticals - Motley Fool
    ... now is a great time to buy several ... Last quarter, sales of diabetes drug Invokana tripled year-over-year to ... the drug outperformed ...
    07/4/2015 - 2:11 pm | View Link
  • More
  • AstraZeneca diabetes drug gets green light in EU
    The drug is the first to combine a new class of diabetes medication known as SGLT2 ... in December 2013. AstraZeneca is to pay as much as $4.3bn (£2.5bn) to buy out Bristol-Myers Squibb’s half of the diabetes business the two companies developed ...
    01/21/2014 - 11:00 am | View Link
  • AstraZeneca to buy Bristol stake in diabetes venture for up to $4.1 bln
    Speculation that such a deal might be on the cards was fuelled last month after Bristol decided to exit diabetes drug research. The Bristol-AstraZeneca diabetes joint venture includes the oral medicines Onglyza, Kombiglyze and Forxiga, as well as the ...
    12/18/2013 - 8:18 pm | View Link
  • AstraZeneca to buy Bristol out of diabetes venture for up to $4.1 billion
    The move will bulk up AstraZeneca's thin drug portfolio and give Bristol ... Speculation that AstraZeneca might look to buy out Bristol was fuelled last month when the U.S.-based company decided to get out of diabetes research. The decision to quit ...
    12/18/2013 - 7:07 pm | View Link
  • AstraZeneca could buy Bristol stake in diabetes JV: analyst
    AstraZeneca may seek to increase its stake in a diabetes joint venture with Bristol-Myers Squibb, following a decision by the U.S. firm to exit diabetes drug research, according to Citi. Bristol said on Thursday it would no longer conduct research to ...
    11/8/2013 - 5:38 am | View Link
  • Bristol-Myers to buy diabetes drug maker for $5B
    (AP) — Drug maker Bristol-Myers Squibb Co. says it agreed to buy diabetes drug maker Amylin Pharmaceuticals for about $5 billion in cash. Bristol-Myers says it will pay $31 per share for Amylin in a cash tender offer. Including Amylin's debt and a ...
    07/1/2012 - 6:42 am | View Link
  • More
  • Prednisone Disease Interactions
    Comprehensive disease interaction information for prednisone. Includes Corticosteroids - (+) Tuberculin Test.
    07/6/2015 - 3:50 pm | View Website
  • Adult Type 2 Diabetes Medication |
    Read information about ONGLYZA® (saxagliptin), an adult type 2 diabetes medication used with diet and exercise to improve glycemic control.
    07/5/2015 - 7:47 pm | View Website
  • Dr. Neal Barnard's Program for Reversing Diabetes: The ...
    Dr. Neal Barnard's Program for Reversing Diabetes: The Scientifically Proven System for Reversing Diabetes Without Drugs MP3 CD – Audiobook, MP3 Audio, Unabridged
    07/5/2015 - 6:21 pm | View Website
  • AstraZeneca to buy Bristol-Myers Squibb's stake in ...
    AstraZeneca announced Thursday an agreement to acquire Bristol-Myers Squibb's stake in the companies' diabetes joint venture for potentially as much as $4.3 billion ...
    07/5/2015 - 6:07 pm | View Website
  • Buy Onglyza
    Need to buy Onglyza online? Big Mountain Drugs is offering the best prices, detailed information on drug indications, side effects, and precautions.
    07/5/2015 - 2:11 pm | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News